Osteogenic protein-1 increases gene expression of vascular endothelial growth factor in primary cultures of fetal rat calvaria cells

Molecular and Cellular Endocrinology

Volumn 153, Issue 1-2, 1999, Pages 113-124

  Yeh, Lee Chuan C ^a   Lee, John C ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

BMP; Osteoblast; Osteogenic protein 1; VEGF expression

Indexed keywords

MESSENGER RNA; OSTEOGENIC PROTEIN 1; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CALVARIA; CELL CULTURE; CELL PROLIFERATION; FETUS; GENE EXPRESSION SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEINS; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELLS, CULTURED; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; KINETICS; LYMPHOKINES; OLIGONUCLEOTIDES, ANTISENSE; RATS; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURAMIN; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0033587653     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00076-3     Document Type: Article

References (47)

1. Andrews P.W., Damjanov I., Berends J., Kumpf S., Zappavigna V., Mavilio F., Sampath T.K. Inhibition of proliferation and induction of differentiation of pluripotent human embryonal carcinoma cells by OP-1 (BMP-7). Lab. Invest. 71:1994;243-251.
2. Aronow M.A., Gerstenfeld L.C., Owen T.A., Tassinari M.S., Stein G.S., Lian J.B. Factors that promote progessive development of the osteoblast phenotype in cultured fetal rat calvarial cells. J. Cell. Physiol. 143:1990;213-221.
3. Asahina I., Sampath T.K., Nishimura I., Hauschka P.V. Human osteogenic protein1 induces both chondroblastic and osteoblastic differentiation of osteoprogenitor cells derived from newborn rat calvaria. J. Cell. Biol. 123:1993;921-933.
4. Bellows C.G., Aubin J.E., Heersche J.N., Antosz M.E. Mineralized bone nodules formed in vitro from enzymatically released rat calvaria cell populations. Calcif. Tissue Int. 38:1986;143-154.
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
6. Carrington J.L., Reddi A.H. Parallels between development of embryonic and matrix-induced endochondral bone. Bioessays. 13:1991;403-408.
7. Centrella M., McCarthy T.L., Canalis E. Glucocorticoid regulation of transforming growth factor β1 activity and binding in osteoblast-enriched cultures from fetal rat bone. Mol. Cell Biol. 11:1991;4490-4496.
8. Centrella M., McCarthy T.L., Kusmik W.F., Canalis E. Relative binding and biochemical effects of heterodimeric and homodimeric isoforms of platelet-derived growth factor in osteoblast-enriched cultures of fetal rat bone. J. Cell Physiol. 147:1991;420-426.
9. Collin-Osdoby P. Role of vascular endothelial cells in bone biology. J. Cell Biochem. 55:1994;304-309.
10. Conn G., Bayne M.L., Soderman D.D., Kwok P.W., Sullivan K.A., Palisi T.M., Hope D.A. Amino acid and cDNA sequences of a vascular entothelial cell mitogen that is homologous to platelet-derived growth factor. Proc. Natl. Acad. Sci. USA. 87:1990;2628-2632.
11. Cook S.D., Baffes G.C., Sampath T.K., Rueger D.C. Healing of large segmental defects using recombinant human osteogenic protein (rhOP-1). Trans. Orthop. Res. Soc. 17:1992;581-587.
12. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Reuger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin. Orthop. Rel. Res. 301:1994;302-312.
13. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Reuger D.C., Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J. Bone Joint Surg. Am. 76:1994;827-838.
14. Cullinan-Bove K., Koos R.D. Vascular endothelial growth factor/vascular permeability factor expression in the rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology. 133:1993;829-837.
15. De Vries C., Escobedo J.A., Ueno H., Houck K., Ferrara N., Williams L.T. The fins-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science. 255:1992;989-991.
16. Decker B., Bartels H., Decker S. Relationships between endothelial cells, periocytes, and osteoblasts during bone formation in the sheep femur following implantation of tricalciumphosphate-ceramic. Anat. Rec. 242:1995;310-320.
17. Drury R.A.B., Wallington E.A. Modified von Kossa Method in Carleton's Histological Technique. 5th edition:1980;217-218 Oxford University Press.
18. Ferrara N., Davis-Smyth T. The Biology of vascular endothelial growth factor. Endocr. Rev. 18:1997;4-25.
19. Goad D.L., Rubin J., Wang H., Tashjian A.H. Jr., Patterson C. Enhanced expression of vascular endothelial growth factor in human SaOS-2 osteoblast-like cells and murine osteoblasts induced by insulin-like growth factor I. Endocrinology. 137:1996;2262-2268.
20. 1 in osteoblasts. J. Clin. Invest. 93:1994;2490-2496.
21. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594.
22. Houck K.A., Ferrara N., Winer J., Cachianes G., Li B., Leung D.W. The vascular endothelial growth factor family: Identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5:1991;1806-1814.
23. Kitten, A.M., Lee, J.C., Olson, M.S., 1995. Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells. Am. J. Physiol. 269 (Endocrinol. Metab. 32), E918-E926.
24. Knutsen R., Honda Y., Strong D.D., Sampath T.K., Baylink D.J., Mohan S. Regulation of insulin-like growth factor system components by osteogenic protein-1 in human bone cells. Endocrinology. 136:1995;857-865.
25. Knutsen R., Wergedal J.E., Sampath T.K., Baylink D.J., Mohan S. Osteogenic protein-1 stimulates proliferation and differentiation of human bone cells in vitro. Biochem. Biophys. Res. Commun. 194:1993;1352-1358.
26. Li I.W.S., Cheifeetz S., McCulloch C.A.G., Sampath T.K., Sodek J. Effects of osteogenic protein-1 (OP-1, BMP-7) on bone matrix protein expression by fetal rat calvaria cells are differentiation state specific. J. Cell. Physiol. 169:1996;115-125.
27. Maliakal J.C., Asahina I., Hauschka P.V., Sampath T.K. OP-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors. 11:1994;227-234.
28. McCarthy T.L., Centrella M., Canalis E. Further biochemical and molecular characterization of primary rat parietal bone cell cultures. J. Bone Miner. Res. 3:1988;401-408.
29. Midy V., Plouet J. Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts. Biochem. Biophys. Res. Commun. 199:1994;380-386.
30. Nomura M., Yamagishi S., Harada S., Hayashi Y., Yamashima T., Yamashita J., Yamamoto H. Possible participation of autocrine and paracrine vascular endothelial growth factors in hypoxia-induced proliferation of endothelial cells and pericytes. J. Biol. Chem. 270:1995;28316-28324.
31. Ozkaynak E., Rueger D.C., Drier E.A., Corbett C., Ridge R.J., Sampath T.K., Oppermann H. OP-1 cDNA encodes an osteogenic protein in the TGF-β family. EMBO J. 9:1990;2085-2093.
32. Quinn T.P., Peters K.G., De Vries C., Ferrara N., Williams L.T. Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Nat.l. Acad. Sci. USA. 90:1993;7533-7537.
33. Sampath T.K., Coughlin J.E., Whetstone R.M., Banach D., Corbett C., Ridge R.J., Ozkaynak E., Oppermann H., Rueger D.C. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J. Biol. Chem. 265:1990;13198-13205.
34. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H.L., Corbett C., Ozkaynak E., Oppermann H., Rueger D.C. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:1992;20352-20362.
35. Schlaeppi J.M., Gutzwiller S., Finkenzeller G., Fournier B. 1,25-dihydroxyvitamin D3 induces the expression of vascular endothelial growth factor in osteoblastic cells. Endocrinol. Res. 23:1997;213-229.
36. Sodek J., Chen J., Nagata T., Kasugai S., Todescan R. Jr., Li I.W., Kim R.H. Regulation of osteopontin expression in osteoblasts. Ann. New York Acad. Sci. 760:1995;223-241.
37. Streeten E.A., Brandi M.L. Biology of bone endothelial cells. Bone Miner. 10:1990;85-94.
38. Trueta J. The role of the vessels in osteogenesis. J. Bone Joint Surg. 45B:1963;402-418.
39. Waltenberger J., Mayr U., Frank H., Hombach V. Suramin is a potent inhibitor of vascular endothelial growth factor. A contribution to the molecular basis of its antiangiogenic action. J. Mol. Cell Cardiol. 28:1996;1523-1529.
40. Wang D.S., Miura M., Demura H., Sato K. Anabolic effects of 1,25-dihydroxyvitamin D3 on osteoblasts are enhanced by vascular endothelial growth factor produced by osteoblasts and by growth factors produced by endothelial cells. Endocrinology. 138:1997;2953-2962.
41. Wang D.S., Yamazaki K., Nohtomi K., Shizume K., Ohsumi K., Shibuya M., Demura H., Sato K. Increase of vascular endothelial growth factor mRNA expression by 1,25-dihydroxyvitamin D3 in human osteoblast-like cells. J. Bone Miner. Res. 11:1996;472-479.
42. Wen Y., Edelman J.L., Kany T., Zeng N., Sachs G. Two functional forms of vasacular endothelial growth factor receptor-2/flk-1 rnRNA are expressed in normal rat retina. J. Biol. Chem. 273:1998;1090-1097.
43. Wozney J.M. Bone morphogenetic proteins and their gene expression. Noda M. Cellular and Molecular Biology of Bone. 1993;131-167 Academic Press, San Diego.
44. Yamane A., Seetharam L., Yamaguchi S., Gotoh N., Takashi T., Nenfeld G., Shibuya M. A new communication system between hepatocytes and sinusoidal endothelial cells in liver through vascular endothelial growth factor and Flt tyrosine kinase receptor family (Flt-1 and KDR/Flk-1). Oncogene. 9:1994;2683-2690.
45. Yamashita H., Shimizu A., Kato M., Nishitoh H., Ichijo H., Hanyu A., Morita I., Kimura M., Makishima F., Miyazono K. Growth/differentiation factor-5 induces angiogenesis in vivo. Exp. Cell Res. 235:1997;218-226.
46. Yeh L.C.C., Adamo M.L., Kitten A.M., Olson M.S., Lee J.C. Osteogenic protein-1-mediated IGF gene expression in primary cultures of rat osteoblastic cells. Endocrinology. 137:1996;1921-1931.
47. Yeh L.C.C., Adamo M.L., Olson M.S., Lee J.C. Osteogenic protein-1 and insulin-like growth factor I synergistically stimulate rat osteoblastic cell differentiation and proliferation. Endocrinology. 138:1997;4181-4190.